Back to Search
Start Over
The role of Pin1 in the development and treatment of cancer.
- Source :
-
Archives of pharmacal research [Arch Pharm Res] 2016 Dec; Vol. 39 (12), pp. 1609-1620. Date of Electronic Publication: 2016 Aug 29. - Publication Year :
- 2016
-
Abstract
- Protein phosphorylation and post-phosphorylation events regulate many cellular signaling pathways. Peptidyl-prolyl isomerase (Pin1) is the only peptidyl-prolyl cis/trans isomerase that interacts with numerous oncogenic or tumor suppressive phosphorylated proteins, causes conformational changes in target proteins, and eventually regulates the activities of such proteins. These alterations in activity play a pivotal role in tumorigenesis. Since Pin1 is overexpressed and/or activated in various types of cancers, and the dysregulation of proline-directed phosphorylation contributes to tumorigenesis, Pin1 represents an attractive target for cancer therapy. This review will describe the role of Pin1 in cancer and the current status of Pin1 inhibitor development.
- Subjects :
- Animals
Antineoplastic Agents pharmacology
Carcinogenesis drug effects
Enzyme Inhibitors pharmacology
Enzyme Inhibitors therapeutic use
Humans
Signal Transduction drug effects
Signal Transduction physiology
Treatment Outcome
Antineoplastic Agents therapeutic use
Carcinogenesis metabolism
NIMA-Interacting Peptidylprolyl Isomerase antagonists & inhibitors
NIMA-Interacting Peptidylprolyl Isomerase metabolism
Neoplasms drug therapy
Neoplasms enzymology
Subjects
Details
- Language :
- English
- ISSN :
- 1976-3786
- Volume :
- 39
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- Archives of pharmacal research
- Publication Type :
- Academic Journal
- Accession number :
- 27572155
- Full Text :
- https://doi.org/10.1007/s12272-016-0821-x